AnalystsJason ButlerJason Butler's Stock Forecasts
AnalystsJason Butler
Sectors:
Analyst Ranking
Top 29%
#1293 out of 4560 analysts
Average Return
+1.44%
Win Rate
38%40 out of 104
Risk vs Reward
Poor
Good
Jason Butler's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Morphosys AgMOR | +296.48% | $4.55 | $18.04 | 2023-11-20 - 2024-04-23 | Buy |
Rezolute IncRZLT | +262.03% | $0.79 | $2.86 | 2023-11-13 - 2024-04-23 | Buy |
Prothena Corp Public Ltd CoPRTA | +170.41% | $25.75 | $69.63 | 2022-05-24 - 2023-05-24 | Buy |
Aquestive Therapeutics IncAQST | +162.58% | $1.63 | $4.28 | 2023-09-20 - 2024-04-23 | Buy |
Aquestive Therapeutics IncAQST | +159.39% | $1.65 | $4.28 | 2023-06-29 - 2024-04-23 | Buy |
Jason Butler Analyst Color
Get additional color on Jason Butler's coverage of popular stocks
Jason Butler's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Vigil Neuroscience IncVIGL | 3 | Buy | $23.00 | +767.92% | Reiterates | 5 days ago |
Rezolute IncRZLT | 6 | Buy | $7.00 | +144.76% | Reiterates | 5 days ago |
Cormedix IncCRMD | 6 | Buy | $19.00 | +248.62% | Reiterates | 15 days ago |
Argenx SeARGX | 4 | Buy | $471.00 | +25.57% | Reiterates | a month ago |
Precigen IncPGEN | 5 | Buy | $14.00 | +900.00% | Reiterates | a month ago |
Aquestive Therapeutics IncAQST | 3 | Buy | $10.00 | +133.64% | Maintains | a month ago |
Acadia Pharmaceuticals IncACAD | 11 | Buy | $39.00 | +132.97% | Maintains | a month ago |
Gh Research PLCGHRS | 3 | Buy | $39.00 | +245.13% | Maintains | 2 months ago |
Halozyme Therapeutics IncHALO | 7 | Buy | $72.00 | +84.76% | Reiterates | 2 months ago |
Prothena Corp Public Ltd CoPRTA | 6 | Buy | $85.00 | +313.42% | Maintains | 2 months ago |
Morphosys AgMOR | 3 | Buy | $17.00 | -5.76% | Reiterates | 5 months ago |
Karuna Therapeutics IncKRTX | 6 | Buy | $318.00 | -3.59% | Reiterates | 5 months ago |
Viridian Therapeutics IncVRDN | 5 | Buy | $38.00 | +166.67% | Maintains | 5 months ago |
Cytokinetics IncCYTK | 7 | Buy | $71.00 | +8.28% | Reiterates | 7 months ago |
Gamida Cell LtdGMDAQ | 9 | Buy | $6.00 | +18,081.82% | Reiterates | 7 months ago |
Ironwood Pharmaceuticals IncIRWD | 1 | Buy | $22.00 | +164.74% | Initiates Coverage On | 7 months ago |
Athira Pharma IncATHA | 3 | Buy | $19.00 | +831.37% | Maintains | 8 months ago |
Trevena IncTRVN | 2 | Buy | $2.00 | +415.46% | Reiterates | a year ago |
Syros Pharmaceuticals IncSYRS | 2 | Buy | $15.00 | +191.83% | Maintains | a year ago |
Minerva Neurosciences IncNERV | 1 | Hold | N/A | N/A | Downgrades | 2 years ago |
Plx Pharma IncPLXPQ | 1 | Hold | N/A | N/A | Downgrades | 2 years ago |
Applied Molecular Transport IncAMTI | 2 | Buy | $50.00 | N/A | Maintains | 2 years ago |
Marinus Pharmaceuticals IncMRNS | 2 | Buy | $22.00 | N/A | Maintains | 2 years ago |
Quince Therapeutics IncQNCX | 1 | Hold | N/A | N/A | Downgrades | 2 years ago |
Arena Pharmaceuticals IncARNA | 1 | Hold | N/A | N/A | Downgrades | 2 years ago |
Enanta Pharmaceuticals IncENTA | 4 | Buy | $116.00 | N/A | Maintains | 2 years ago |
Hookipa Pharma IncHOOK | 1 | Buy | $11.00 | N/A | Maintains | 2 years ago |
Arbutus Biopharma CorpABUS | 1 | Buy | $9.00 | N/A | Maintains | 2 years ago |
Adamas Pharmaceuticals IncADMS | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
Esperion Therapeutics IncESPR | 1 | Buy | $111.00 | N/A | Maintains | 3 years ago |
Ovid Therapeutics IncOVID | 1 | Hold | N/A | N/A | Downgrades | 3 years ago |
Pfenex IncPFNX | 1 | Hold | N/A | N/A | Downgrades | 4 years ago |
Zogenix IncZGNX | 1 | Buy | $56.00 | N/A | Initiates Coverage On | 6 years ago |
Intra Cellular Therapies IncITCI | 1 | Buy | N/A | N/A | Upgrades | 7 years ago |
Forward Pharma AFWPAY | 1 | Hold | N/A | N/A | Downgrades | 7 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.